Medaysis develops and delivers products for immunohistochemistry (IHC), immunofluorescence (IF), and PCR applications. We are passionate and strive to provide advanced technologies and quality solutions that will empower the innovation and improve the practice of anatomic and molecular pathology professionals, ultimately to develop accurate diagnostic assays and personalized healthcare to benefit the patients and well-being of individuals around the world.